ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,110 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryLausanneOculis Operations Sàrl
Oculis Operations Sàrl Logo
Verified· 3 sources

Oculis Operations Sàrl

Summary

About the company

The core activity of Oculis is the development and research of innovative treatments and medications for eye diseases, particularly in the areas of Diabetic Maculopathy, dry eye, Uveitis and acute Optic Neuritis. The company focuses on developing highly effective and patient-centered solutions to improve the treatment of eye diseases and preserve patients' vision.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Ophthalmic Drug Development
Development of ophthalmic drug candidates and therapies for eye diseases, with a focus on neuro-ophthalmology and ophthalmology programs in the clinical pipeline.
Optic Neuritis Therapy
Therapy development for optic neuritis with Privosegtor as an investigational candidate; aimed at neuroprotective treatment of optic nerve inflammation without an approved specific therapy.
NAION Therapy
Therapy development for non-arteritic anterior ischemic optic neuropathy (NAION) with Privosegtor as an investigational candidate for neuroprotective treatment.
Dry Eye Disease Therapy
Therapy development for dry eye disease with Licaminlimab as an anti-TNFα eye-drop candidate designed to treat ocular inflammation.
Press

Media

March 5, 2026Media
«Vous devez transformer votre entreprise pour entrer au Nasdaq»
pme.ch

Knowledge

No knowledge articles yet

Once Oculis Operations Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Oculis Operations Sàrl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Oculis Operations Sàrl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Oculis Operations Sàrl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Avenue de la Gare 39
1003 Lausanne
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Limited Liability Company
UID
CHE-284.087.350
Founded
2022 · 4 years
Last commercial register change
July 21, 2026
Employees
21 to 50

Similar companies

GM
Grand Medical Group AG
Lausanne
RS
ReproNovo SA
Lausanne
AT
Avrion Therapeutics SA
Lausanne
TP
Tigen Pharma SA
Lausanne
CS
Copexis SA
La Conversion
HP
Horus Pharma Suisse SA
Nyon
AT
ADC Therapeutics SA
Epalinges
AS
Asceneuron SA
Eysins